Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 2.942.772.742.942.97

What is the latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of GLENMARK PHARMACEUTICALS is 2.94 based on Mar2025 Consolidated results.
Year Sales/Fixed Asset
Mar20252.94
Mar20242.77
Mar20232.74
Mar20222.94
Mar20212.97

How is Sales/Fixed Asset of GLENMARK PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2025 2.94
6.14
Mar2024 2.77
1.09
Mar2023 2.74
-6.80
Mar2022 2.94
-1.01
Mar2021 2.97 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,584.5 Cr 1% -8.5% 37.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1%

-8.5%

37.3%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses